Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Miller

Showing results (191-200 of 235) with videos related to

Pageof 24
Sort By:
Cell Stem Cell|May 1, 2012
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cellsMargaret A Young, David E Larson, Chiao-Wang Sun, et al.
Plos Genetics|July 11, 2014
Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencingAndrew E O Hughes, Vincent Magrini, Ryan Demeter, et al.
Blood|November 3, 2017
Somatic mutations and clonal hematopoiesis in congenital neutropeniaJun Xia, Christopher A Miller, Jack Baty, et al.
Blood|January 14, 2017
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapyEric J Duncavage, Geoffrey L Uy, Allegra A Petti, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Genomic landscape of <i>TP53</i> -mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Nature Communications|November 10, 2016
Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivationPascal Gellert, Corrinne V Segal, Qiong Gao, et al.
Nature|December 10, 2014
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaTerrence N Wong, Giridharan Ramsingh, Andrew L Young, et al.
Experimental Hematology|August 2, 2017
Comprehensive discovery of noncoding RNAs in acute myeloid leukemia cell transcriptomesJin Zhang, Malachi Griffith, Christopher A Miller, et al.
Nature Communications|February 2, 2018
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potentialTerrence N Wong, Christopher A Miller, Matthew R M Jotte, et al.
Nature Methods|October 15, 2013
DGIdb: mining the druggable genomeMalachi Griffith, Obi L Griffith, Adam C Coffman, et al.
Pageof 24

Showing results (191-200 of 235) with videos related to

Sort By:
Pageof 24
Cell Stem Cell|May 1, 2012
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cellsMargaret A Young, David E Larson, Chiao-Wang Sun, et al.
Plos Genetics|July 11, 2014
Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencingAndrew E O Hughes, Vincent Magrini, Ryan Demeter, et al.
Blood|November 3, 2017
Somatic mutations and clonal hematopoiesis in congenital neutropeniaJun Xia, Christopher A Miller, Jack Baty, et al.
Blood|January 14, 2017
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapyEric J Duncavage, Geoffrey L Uy, Allegra A Petti, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Genomic landscape of <i>TP53</i> -mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Nature Communications|November 10, 2016
Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivationPascal Gellert, Corrinne V Segal, Qiong Gao, et al.
Nature|December 10, 2014
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaTerrence N Wong, Giridharan Ramsingh, Andrew L Young, et al.
Experimental Hematology|August 2, 2017
Comprehensive discovery of noncoding RNAs in acute myeloid leukemia cell transcriptomesJin Zhang, Malachi Griffith, Christopher A Miller, et al.
Nature Communications|February 2, 2018
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potentialTerrence N Wong, Christopher A Miller, Matthew R M Jotte, et al.
Nature Methods|October 15, 2013
DGIdb: mining the druggable genomeMalachi Griffith, Obi L Griffith, Adam C Coffman, et al.
Pageof 24